Published in Trends Endocrinol Metab on September 25, 2006
Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell (2008) 4.20
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies. Cancer (2008) 2.11
c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development. Blood (2010) 1.55
Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem Sci (2013) 1.21
Insulinoma: pathophysiology, localization and management. Future Oncol (2010) 1.21
Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Res (2009) 1.05
Molecular genetics of parathyroid disease. World J Surg (2009) 1.01
The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat Commun (2014) 1.00
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore) (2013) 1.00
Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome. Cancer Res (2013) 0.97
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective. Curr Mol Med (2008) 0.94
Regulation of cyclin B2 expression and cell cycle G2/m transition by menin. J Biol Chem (2010) 0.90
Molecular analysis of MEN1 expression in MCF7, T47D and MDA-MB 468 breast cancer cell lines treated with adriamycin using RT-PCR and immunocytochemistry. Daru (2010) 0.85
Menin represses tumorigenesis via repressing cell proliferation. Am J Cancer Res (2011) 0.85
MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair. DNA Repair (Amst) (2008) 0.82
Menin: a tumor suppressor that mediates postsynaptic receptor expression and synaptogenesis between central neurons of Lymnaea stagnalis. PLoS One (2014) 0.79
The role of genetic and epigenetic changes in pituitary tumorigenesis. Neurol Med Chir (Tokyo) (2014) 0.78
Pituitary tumors in patients with MEN1 syndrome. Clinics (Sao Paulo) (2012) 0.75
Impact of a novel 14 bp MEN1 deletion in a patient with hyperparathyroidism and gastrinoma. Endocrinol Diabetes Metab Case Rep (2015) 0.75
Bilateral granulosa cell tumors: a novel malignant manifestation of multiple endocrine neoplasia 1 syndrome found in a patient with a rare menin in-frame deletion. Appl Clin Genet (2015) 0.75
Spatial Interplay between Polycomb and Trithorax Complexes Controls Transcriptional Activity in T Lymphocytes. Mol Cell Biol (2015) 0.75
Epigenetic regulation by the menin pathway. Endocr Relat Cancer (2017) 0.75
Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci U S A (2003) 3.99
Visualization and manipulation of plasma membrane-endoplasmic reticulum contact sites indicates the presence of additional molecular components within the STIM1-Orai1 Complex. J Biol Chem (2007) 3.02
Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev (2004) 2.36
Selective cellular effects of overexpressed pleckstrin-homology domains that recognize PtdIns(3,4,5)P3 suggest their interaction with protein binding partners. J Cell Sci (2005) 1.80
The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling. Endocrinology (2003) 1.49
Signal transduction of the CB1 cannabinoid receptor. J Mol Endocrinol (2009) 1.37
Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr Relat Cancer (2009) 1.33
Targeted expression of the inositol 1,4,5-triphosphate receptor (IP3R) ligand-binding domain releases Ca2+ via endogenous IP3R channels. Proc Natl Acad Sci U S A (2005) 1.24
Crosstalk between TGF-β signaling and the microRNA machinery. Trends Pharmacol Sci (2012) 1.23
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions. J Endocrinol (2008) 1.21
STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci (2009) 1.20
Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker. PLoS One (2010) 1.08
Intracellular trafficking of hormone receptors. Trends Endocrinol Metab (2004) 1.06
Mechanism of angiotensin II-induced superoxide production in cells reconstituted with angiotensin type 1 receptor and the components of NADPH oxidase. J Biol Chem (2007) 1.01
Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. Mol Genet Metab (2004) 1.01
Endoplasmic reticulum: nutrient sensor in physiology and pathology. Trends Endocrinol Metab (2009) 1.01
Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity. Mol Endocrinol (2002) 1.00
Differential pathways of angiotensin II-induced extracellularly regulated kinase 1/2 phosphorylation in specific cell types: role of heparin-binding epidermal growth factor. Mol Endocrinol (2004) 0.99
MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas. Mod Pathol (2010) 0.98
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas. Pituitary (2011) 0.97
Acute depletion of plasma membrane phosphatidylinositol 4,5-bisphosphate impairs specific steps in endocytosis of the G-protein-coupled receptor. J Cell Sci (2012) 0.95
Small-molecule inhibitors of NADPH oxidase 4. J Med Chem (2010) 0.94
Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases. Eur J Pediatr (2007) 0.94
The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity. J Biol Chem (2007) 0.94
Differential beta-arrestin binding of AT1 and AT2 angiotensin receptors. FEBS Lett (2005) 0.94
Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflamm Bowel Dis (2007) 0.93
Mechanisms of angiotensin II-mediated regulation of aldosterone synthase expression in H295R human adrenocortical and rat adrenal glomerulosa cells. Mol Cell Endocrinol (2009) 0.92
Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion (2011) 0.91
Menin dynamics and functional insight: take your partners. Mol Cell Endocrinol (2010) 0.91
Role of the proline-rich domain of dynamin-2 and its interactions with Src homology 3 domains during endocytosis of the AT1 angiotensin receptor. J Biol Chem (2002) 0.88
Novel genetic mutation in the background of Carney complex. Pathol Oncol Res (2012) 0.88
Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors. J Biol Chem (2009) 0.87
Angiotensin II-induced expression of brain-derived neurotrophic factor in human and rat adrenocortical cells. Endocrinology (2010) 0.87
Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation. J Biol Chem (2002) 0.87
Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J Clin Endocrinol Metab (2010) 0.86
Mapping of the localization of type 1 angiotensin receptor in membrane microdomains using bioluminescence resonance energy transfer-based sensors. J Biol Chem (2012) 0.86
Cushing's syndrome in a child with pancreatic acinar cell carcinoma. Endocr Pathol (2007) 0.86
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro. Am J Physiol Endocrinol Metab (2012) 0.86
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors. J Biol Chem (2012) 0.85
BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism. Clin Endocrinol (Oxf) (2009) 0.85
Gastrointestinal stromal tumor presenting as a hormonally inactive adrenal mass. Endocrine (2011) 0.85
Interactions between conserved residues in transmembrane helices 2 and 7 during angiotensin AT1 receptor activation. Chem Biol Drug Des (2006) 0.84
Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol (2009) 0.84
[Verner-Morrison syndrome: a case study]. Orv Hetil (2010) 0.83
Differential β-arrestin2 requirements for constitutive and agonist-induced internalization of the CB1 cannabinoid receptor. Mol Cell Endocrinol (2013) 0.83
High prevalence of PROP1 gene mutations in Hungarian patients with childhood-onset combined anterior pituitary hormone deficiency. Endocrine (2006) 0.83
Marked chromogranin A elevation in a patient with bilateral adrenal incidentalomas, and its rapid normalization after discontinuation of proton pump inhibitor therapy. Clin Endocrinol (Oxf) (2007) 0.82
AT1 receptor blocker-insensitive mutant AT1A angiotensin receptors reveal the presence of G protein-independent signaling in C9 cells. Biochem Pharmacol (2007) 0.82
Switch from ER-mitochondrial to SR-mitochondrial calcium coupling during muscle differentiation. Cell Calcium (2012) 0.82
Allosteric interactions within the AT₁ angiotensin receptor homodimer: role of the conserved DRY motif. Biochem Pharmacol (2012) 0.82
Primary malignant melanoma of adrenal gland in a 41-yr-old woman. Endocr Pathol (2003) 0.82
Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action. Mol Cell Endocrinol (2011) 0.82
[Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal]. Orv Hetil (2007) 0.82
Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Clin Endocrinol (Oxf) (2007) 0.81
Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas. Eur J Endocrinol (2002) 0.81
A rapid and simple method for detection of Asn363Ser polymorphism of the human glucocorticoid receptor gene. J Steroid Biochem Mol Biol (2005) 0.81
Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene. J Clin Endocrinol Metab (2002) 0.81
Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes. Eur J Clin Invest (2015) 0.81
Serum thyroglobulin antibody levels within or near to the reference range may interfere with thyroglobulin measurement. Biochem Med (Zagreb) (2012) 0.80
[Acromegaly: a disorder with distinguished features yet delayed diagnosis]. Orv Hetil (2002) 0.80
Coeliac disease in a 15-year period of observation (1997 and 2011) in a Hungarian referral centre. Eur J Intern Med (2013) 0.80
Markov model-based estimation of individual survival probability for medullary thyroid cancer patients. Pathol Oncol Res (2002) 0.80
Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes. Pathol Oncol Res (2011) 0.80
Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome. Steroids (2011) 0.80
Peptide and nonpeptide antagonist interaction with constitutively active human AT1 receptors. Biochem Pharmacol (2003) 0.80
Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein. J Endocrinol (2008) 0.80
Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer. Cell Mol Life Sci (2013) 0.80
Endocytosis of the AT1A angiotensin receptor is independent of ubiquitylation of its cytoplasmic serine/threonine-rich region. Int J Biochem Cell Biol (2003) 0.80
Demonstration of angiotensin II-induced Ras activation in the trans-Golgi network and endoplasmic reticulum using bioluminescence resonance energy transfer-based biosensors. J Biol Chem (2010) 0.79
Effect of inhibitors of myeloperoxidase on the development of aortic atherosclerosis in an animal model. Exp Gerontol (2005) 0.79
Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells. Eur J Pharmacol (2005) 0.79
[Macroprolactinemia associated with pituitary macroadenoma: treatment with quinagolide]. Orv Hetil (2010) 0.79
MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy. Cell Mol Life Sci (2014) 0.78
Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study. Pharmacogenomics (2012) 0.78
Detection of hydrogen peroxide by lactoperoxidase-mediated dityrosine formation. Free Radic Res (2009) 0.78
Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus. Mol Endocrinol (2014) 0.78
Recovery and aging of serotonergic fibers after single and intermittent MDMA treatment in Dark Agouti rat. J Comp Neurol (2011) 0.78
Cross-inhibition of angiotensin AT1 receptors supports the concept of receptor oligomerization. Neurochem Int (2007) 0.78
Intraspecific evolution of human RCCX copy number variation traced by haplotypes of the CYP21A2 gene. Genome Biol Evol (2013) 0.78
Tissue-Specific Glucocorticoid Signaling May Determine The Resistance Against Glucocorticoids In Autoimmune Diseases. Curr Med Chem (2014) 0.78